DAXOR CORPORATION - CLOSED END FUND
9.3900
25-November-24 12:00:50
15 minutes delayed
Stocks
+0.1058
+1.14%
Today's range
9.0022 - 9.4800
ISIN
N/A
Source
NASDAQ
-
Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients
23 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
-
03 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
02 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
01 Mar 2023 07:00:02 By Nasdaq GlobeNewswire
-
Daxor Corporation Appoints Linda Cooper, Vice President Project Management
17 Feb 2023 07:00:00 By Nasdaq GlobeNewswire
-
Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member
19 Jan 2023 07:00:01 By Nasdaq GlobeNewswire
-
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress
13 Jan 2023 07:00:00 By Nasdaq GlobeNewswire
-
03 Jan 2023 07:00:01 By Nasdaq GlobeNewswire
-
17 Nov 2022 10:07:00 By Nasdaq GlobeNewswire
-
Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering
15 Nov 2022 07:45:00 By Nasdaq GlobeNewswire
-
Daxor Corporation Announces Launch of Proposed Underwritten Public Offering
14 Nov 2022 16:03:51 By Nasdaq GlobeNewswire
-
10 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
03 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022
31 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
05 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
04 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
03 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
03 Oct 2022 07:40:00 By Nasdaq GlobeNewswire
-
03 Oct 2022 07:00:01 By Nasdaq GlobeNewswire